Literature DB >> 12041662

Mast cells derived from embryonic stem cells: a model system for studying the effects of genetic manipulations on mast cell development, phenotype, and function in vitro and in vivo.

Mindy Tsai1, See-Ying Tam, Jochen Wedemeyer, Stephen J Galli.   

Abstract

Large quantities of highly enriched populations of mast cells can be generated from mouse embryonic stem (ES) cells using an in vitro differentiation system. These embryonic stem cell-derived mast cells (ESMCs) exhibit many similarities to mouse bone marrow-derived cultured mast cells (BMCMCs), including the abilities to survive and to orchestrate immunologically specific immunoglobulin E (IgE)-dependent reactions in vivo after transplantation into genetically mast cell-deficient KitW/KitW-v mice. Coupled with the current spectrum of techniques for genetically manipulating ES cells, ESMCs represent a unique model system to analyze the effects of specific alterations in gene structure, expression, or function, including embryonic lethal mutations, on mast cell development, phenotype, and function in vitro and in vivo.

Entities:  

Mesh:

Year:  2002        PMID: 12041662     DOI: 10.1007/bf02982122

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  18 in total

1.  Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells.

Authors:  S H Lee; N Lumelsky; L Studer; J M Auerbach; R D McKay
Journal:  Nat Biotechnol       Date:  2000-06       Impact factor: 54.908

2.  Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets.

Authors:  N Lumelsky; O Blondel; P Laeng; I Velasco; R Ravin; R McKay
Journal:  Science       Date:  2001-04-26       Impact factor: 47.728

3.  Human embryonic stem cells: the future is now.

Authors:  G Keller; H R Snodgrass
Journal:  Nat Med       Date:  1999-02       Impact factor: 53.440

4.  Transcription factor GATA-2 is required for proliferation/survival of early hematopoietic cells and mast cell formation, but not for erythroid and myeloid terminal differentiation.

Authors:  F Y Tsai; S H Orkin
Journal:  Blood       Date:  1997-05-15       Impact factor: 22.113

5.  Establishment in culture of pluripotential cells from mouse embryos.

Authors:  M J Evans; M H Kaufman
Journal:  Nature       Date:  1981-07-09       Impact factor: 49.962

6.  MEKK2 gene disruption causes loss of cytokine production in response to IgE and c-Kit ligand stimulation of ES cell-derived mast cells.

Authors:  T P Garrington; T Ishizuka; P J Papst; K Chayama; S Webb; T Yujiri; W Sun; S Sather; D M Russell; S B Gibson; G Keller; E W Gelfand; G L Johnson
Journal:  EMBO J       Date:  2000-10-16       Impact factor: 11.598

7.  Hematopoietic commitment during embryonic stem cell differentiation in culture.

Authors:  G Keller; M Kennedy; T Papayannopoulou; M V Wiles
Journal:  Mol Cell Biol       Date:  1993-01       Impact factor: 4.272

8.  An early haematopoietic defect in mice lacking the transcription factor GATA-2.

Authors:  F Y Tsai; G Keller; F C Kuo; M Weiss; J Chen; M Rosenblatt; F W Alt; S H Orkin
Journal:  Nature       Date:  1994-09-15       Impact factor: 49.962

9.  Multiple hematopoietic lineages develop from embryonic stem (ES) cells in culture.

Authors:  M V Wiles; G Keller
Journal:  Development       Date:  1991-02       Impact factor: 6.868

10.  The vav proto-oncogene is required early in embryogenesis but not for hematopoietic development in vitro.

Authors:  A Zmuidzinas; K D Fischer; S A Lira; L Forrester; S Bryant; A Bernstein; M Barbacid
Journal:  EMBO J       Date:  1995-01-03       Impact factor: 11.598

View more
  16 in total

Review 1.  Analyzing the roles of mast cells and basophils in host defense and other biological responses.

Authors:  Stephen J Galli; Jochen Wedemeyer; Mindy Tsai
Journal:  Int J Hematol       Date:  2002-05       Impact factor: 2.490

2.  Differences in the Importance of Mast Cells, Basophils, IgE, and IgG versus That of CD4+ T Cells and ILC2 Cells in Primary and Secondary Immunity to Strongyloides venezuelensis.

Authors:  Kaori Mukai; Hajime Karasuyama; Kenji Kabashima; Masato Kubo; Stephen J Galli
Journal:  Infect Immun       Date:  2017-04-21       Impact factor: 3.441

Review 3.  Mast cells: versatile regulators of inflammation, tissue remodeling, host defense and homeostasis.

Authors:  Stephen J Galli; Mindy Tsai
Journal:  J Dermatol Sci       Date:  2007-11-19       Impact factor: 4.563

4.  Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice.

Authors:  Nicolas Gaudenzio; Riccardo Sibilano; Philipp Starkl; Mindy Tsai; Stephen J Galli; Laurent L Reber
Journal:  J Vis Exp       Date:  2015-05-27       Impact factor: 1.355

Review 5.  Development of mast cells and importance of their tryptase and chymase serine proteases in inflammation and wound healing.

Authors:  Jeffrey Douaiher; Julien Succar; Luca Lancerotto; Michael F Gurish; Dennis P Orgill; Matthew J Hamilton; Steven A Krilis; Richard L Stevens
Journal:  Adv Immunol       Date:  2014       Impact factor: 3.543

Review 6.  Designer blood: creating hematopoietic lineages from embryonic stem cells.

Authors:  Abby L Olsen; David L Stachura; Mitchell J Weiss
Journal:  Blood       Date:  2005-10-27       Impact factor: 22.113

7.  Mast cell-deficient W-sash c-kit mutant Kit W-sh/W-sh mice as a model for investigating mast cell biology in vivo.

Authors:  Michele A Grimbaldeston; Ching-Cheng Chen; Adrian M Piliponsky; Mindy Tsai; See-Ying Tam; Stephen J Galli
Journal:  Am J Pathol       Date:  2005-09       Impact factor: 4.307

8.  Mast cells mediate acute kidney injury through the production of TNF.

Authors:  Shaun A Summers; Jacky Chan; Poh-Yi Gan; Lakshi Dewage; Yuji Nozaki; Oliver M Steinmetz; David J Nikolic-Paterson; A Richard Kitching; Stephen R Holdsworth
Journal:  J Am Soc Nephrol       Date:  2011-10-21       Impact factor: 10.121

9.  Evidence for the role of mast cells in colon-bladder cross organ sensitization.

Authors:  Jocelyn J Fitzgerald; Elena Ustinova; Kevin B Koronowski; William C de Groat; Michael A Pezzone
Journal:  Auton Neurosci       Date:  2012-11-24       Impact factor: 3.145

Review 10.  Autologous blood cell therapies from pluripotent stem cells.

Authors:  Claudia Lengerke; George Q Daley
Journal:  Blood Rev       Date:  2009-11-11       Impact factor: 8.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.